RHYTHM PHARMACEUTICALS, INC. Temporary Equity, Liquidation Preference
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Temporary Equity, Liquidation Preference of $0 as of 2017-12-31, per its 8-K filed 2018-11-09.
Discontinued › Balance Sheet › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2018-11-09
- 2017-12-31: Temporary Equity, Liquidation Preference $0.00.
- 2017-09-30: Temporary Equity, Liquidation Preference $88.86M.
- 2016-12-31: Temporary Equity, Liquidation Preference $44.13M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2017-12-31 | $0.00 8-K · filed 2018-11-09 |
| 2017-09-30 | $88.86M 10-Q · filed 2017-11-14 |
| 2016-12-31 | $44.13M 8-K · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |